Artiva Biotherapeutics, Inc. · NASDAQ:ARTV
Viking Global Investors LP reported a 5.40% stake in Artiva Biotherapeutics, Inc. (Schedule 13G)
Event May 11, 2026 · Filed May 18, 2026
Viking Global Investors LP reported a 5.40% stake in Artiva Biotherapeutics, Inc., 2,604,166 shares, as a passive investor on May 11, 2026. Filed May 18, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 2,604,166
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 5.40% | 2,604,166 |
| Viking Global Opportunities Parent GP LLC | 5.40% | 2,604,166 |
| Viking Global Opportunities GP LLC | 3.80% | 1,822,916 |
| Viking Global Opportunities Portfolio GP LLC | 3.80% | 1,822,916 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 3.80% | 1,822,916 |
| Viking Global Opportunities Vintage IV GP LLC | 1.60% | 781,250 |
| Viking Global Opportunities Vintage IV Portfolio GP LLC | 1.60% | 781,250 |
| Viking Global Opportunities Vintage IV (Aggregator) LP | 1.60% | 781,250 |
| HALVORSEN OLE ANDREAS | 5.40% | 2,604,166 |
| Shabet Rose Sharon | 5.40% | 2,604,166 |